Changjiang Life Science and Technology (00775.HK) released its interim results, with a shareholder net loss of 150 million Hong Kong dollars, turning from a year-on-year profit to a loss.

Wise Finance News App, Chongjiang Life Sciences and Technology (00775.HK) released its mid-term performance for 2025. The group achieved a revenue of 2.606 billion Hong Kong dollars, a decrease of 1.14% year-on-year. The company's shareholders had a loss of 150 million Hong Kong dollars, compared to a profit of 1.001 million Hong Kong dollars in the same period last year. Loss per share is 1.57 Hong Kong cents.